Over-prescription of short-acting β2-agonists for asthma in South Africa: Results from the SABINA III study

Over-prescription of short-acting β2-agonists for asthma in South Africa: Results from the SABINA III study

Background. Asthma medication prescription trends, including those of short-acting β2-agonists (SABAs), are not well documented for South Africa (SA). Objectives. To describe demographics, disease characteristics and asthma prescription patterns in the SA cohort of the SABA use IN Asthma (SABINA) II...

Full description

Bibliographic Details
Main Authors: C Smith, A Ambaram, E Mitha, I Abdullah, I A Abdullah, J Reddy, J Trokis, P Ramlachan, U Govind, K Lightfoot, K Moodley, R Smit, M J H I Beekman
Format: Article
Language:English
Published: South African Medical Association 2022-12-01
Series:African Journal of Thoracic and Critical Care Medicine
Subjects:
asthma
over-prescription
sabina
saba
Online Access:https://samajournals.co.za/index.php/ajtccm/article/view/619

Internet

https://samajournals.co.za/index.php/ajtccm/article/view/619

Similar Items